Published in J Thromb Haemost on August 01, 2012
The phenotypic legacy of admixture between modern humans and Neandertals. Science (2016) 2.20
Novel genetic predictors of venous thromboembolism risk in African Americans. Blood (2016) 1.43
Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am J Hum Genet (2015) 1.23
A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet Epidemiol (2013) 1.12
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics (2012) 0.93
ABO Blood Groups and Cardiovascular Diseases. Int J Vasc Med (2012) 0.91
Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study. BMC Med (2015) 0.86
Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Res (2015) 0.82
Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolism. Arterioscler Thromb Vasc Biol (2013) 0.81
Genomic signals of migration and continuity in Britain before the Anglo-Saxons. Nat Commun (2016) 0.79
From Loci to Biology: Functional Genomics of Genome-Wide Association for Coronary Disease. Circ Res (2016) 0.79
Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans. Am J Hematol (2015) 0.79
Environmental and Genetic Risk Factors Associated with Venous Thromboembolism. Semin Thromb Hemost (2016) 0.78
Prevalence of blood type A and risk of vascular complications following transcatheter aortic valve implantation. Neth Heart J (2016) 0.77
Personalized medicine in thrombosis: back to the future. Blood (2016) 0.77
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. PLoS Genet (2016) 0.77
Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism. Thromb Haemost (2016) 0.76
Estrogen and Cardiovascular Disease: Is Timing Everything? Am J Med Sci (2015) 0.75
Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Hematol (2015) 0.75
Functional implications of Neandertal introgression in modern humans. Genome Biol (2017) 0.75
Dissecting the genetic determinants of hemostasis and thrombosis. Curr Opin Hematol (2015) 0.75
Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Thromb Res (2016) 0.75
Phenome-Wide Association Study to Explore Relationships between Immune System Related Genetic Loci and Complex Traits and Diseases. PLoS One (2016) 0.75
A genetic association study of activated partial thromboplastin time in European Americans and African Americans: the ARIC Study. Hum Mol Genet (2014) 0.75
Sex-specific effect of CPB2 Ala147Thr but not Thr325Ile variants on the risk of venous thrombosis: A comprehensive meta-analysis. PLoS One (2017) 0.75
Risk prediction of developing venous thrombosis in combined oral contraceptive users. PLoS One (2017) 0.75
Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis. J Thromb Haemost (2017) 0.75
Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort. Clin Rheumatol (2017) 0.75
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
Inference of population structure using multilocus genotype data. Genetics (2000) 147.76
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res (2010) 97.51
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc (2009) 38.62
Distribution and intensity of constraint in mammalian genomic sequence. Genome Res (2005) 18.85
Genotype imputation. Annu Rev Genomics Hum Genet (2009) 18.64
Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet (2006) 17.36
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature (1994) 9.06
A Hidden Markov Model approach to variation among sites in rate of evolution. Mol Biol Evol (1996) 8.35
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
European population substructure: clustering of northern and southern populations. PLoS Genet (2006) 5.27
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A (1993) 4.57
SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics (2010) 4.02
The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol (2008) 3.50
The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol (2010) 3.48
Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med (2004) 3.25
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med (2002) 3.04
Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98
Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation (2010) 2.78
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood (2009) 2.64
ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost (2007) 2.38
Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13. Blood (2009) 1.81
Platelets, inflammation and tissue regeneration. Thromb Haemost (2011) 1.69
Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet (2000) 1.69
ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost (2007) 1.59
Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control study. J Thromb Haemost (2005) 1.56
SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI Study. Clin Chem (2009) 1.45
Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One (2011) 1.43
Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study. Arterioscler Thromb Vasc Biol (2009) 1.34
The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost (2005) 1.33
Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. J Thromb Haemost (2011) 1.19
ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost (2008) 1.18
Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem (1992) 1.15
P-selectin in haemostasis. Br J Haematol (2004) 1.14
Familial segregation of venous thromboembolism. J Thromb Haemost (2004) 1.08
ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost (2005) 1.08
Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins. Epidemiology (2003) 1.07
Characterization of the molecular defect in factor VR506Q. J Biol Chem (1995) 1.05
Circulating P-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost (2007) 1.04
Increased soluble P-selectin levels following deep venous thrombosis: cause or effect? Br J Haematol (2000) 0.98
A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood (1997) 0.93
The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study. J Thromb Haemost (2005) 0.91
High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. Br J Haematol (2001) 0.85
Phenotypic but not allelic ABO blood group association with risk of venous thrombosis. Thromb Haemost (2005) 0.81
Selectin haplotypes and the risk of venous thrombosis: influence of linkage disequilibrium with the factor V Leiden mutation. J Thromb Haemost (2007) 0.81
P-selectin polymorphisms' influences on P-selectin serum concentrations and on their familial correlation: the STANISLAS family study. J Thromb Haemost (2008) 0.81
Polymorphisms in exons 6 and 7 of the ABO locus and their association with venous thrombosis in young Brazilian patients. Blood Coagul Fibrinolysis (2009) 0.80
Heightened thrombin generation in individuals with resistance to activated protein C. Thromb Haemost (1996) 0.77
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell (1989) 7.64
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature (1991) 5.40
Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell (2000) 4.88
Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem (1992) 4.88
Biochemical evidence that patched is the Hedgehog receptor. Nature (1996) 4.53
Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res (1998) 3.36
Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet (2000) 3.33
Characterization of a human colon/lung carcinoma oncogene. Nature (1983) 3.26
Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science (1997) 3.13
The HL-60 transforming sequence: a ras oncogene coexisting with altered myc genes in hematopoietic tumors. Cell (1983) 3.00
Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98
Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res (1996) 2.89
Envelope-binding domain in the cationic amino acid transporter determines the host range of ecotropic murine retroviruses. J Virol (1993) 2.77
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell (1992) 2.67
Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. Mayo Clin Proc (1995) 2.55
The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci U S A (1987) 2.51
Apparent heterozygote deficiencies observed in DNA typing data and their implications in forensic applications. Ann Hum Genet (1992) 2.32
The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat Genet (1995) 2.30
Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology (2001) 2.30
Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1. Nat Genet (1999) 2.28
Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17
Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood (1999) 2.14
Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin--glycoprotein complex. Neuron (2000) 2.04
The epidemiology of venous thromboembolism in the community. Thromb Haemost (2001) 1.86
Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg (1994) 1.86
Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol (1994) 1.85
Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J (1998) 1.83
Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet (1996) 1.76
Identification of a receptor-binding pocket on the envelope protein of friend murine leukemia virus. J Virol (1999) 1.75
Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet (2000) 1.69
Human cells infected with retrovirus vectors acquire an endogenous murine provirus. J Virol (1990) 1.65
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer (2009) 1.54
Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome. Bone Marrow Transplant (2001) 1.52
Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology (2004) 1.51
Characterization of the third member of the MCAT family of cationic amino acid transporters. Identification of a domain that determines the transport properties of the MCAT proteins. J Biol Chem (1993) 1.49
Neural basis of endogenous and exogenous spatial orienting. A functional MRI study. J Cogn Neurosci (1999) 1.42
In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J Virol (1997) 1.41
Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proc Natl Acad Sci U S A (2001) 1.37
Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. Nat Neurosci (2001) 1.37
Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J Cell Biol (1999) 1.33
Human cationic amino acid transporters hCAT-1, hCAT-2A, and hCAT-2B: three related carriers with distinct transport properties. Biochemistry (1997) 1.33
Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. J Biol Chem (1993) 1.32
SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet (2009) 1.32
N-linked glycosylation of the receptor for murine ecotropic retroviruses is altered in virus-infected cells. J Biol Chem (1993) 1.32
Hemoglobin switching in man and chicken is mediated by a heteromeric complex between the ubiquitous transcription factor CP2 and a developmentally specific protein. EMBO J (1995) 1.30
Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab (2000) 1.28
Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet (1997) 1.25
Induction of human fetal globin gene expression by a novel erythroid factor, NF-E4. Mol Cell Biol (2000) 1.24
Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res (2001) 1.24
The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders. Neurology (2003) 1.22
HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res (2000) 1.20
Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil (2008) 1.19
Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion. J Virol (2001) 1.19
Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism. J Thromb Haemost (2011) 1.19
Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg (1997) 1.15
Minus-strand DNA is present within murine type C ecotropic retroviruses prior to infection. J Virol (1993) 1.14
The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc (2000) 1.13
Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study. J Vasc Surg (2001) 1.13
The activation domain of the enhancer binding protein p45NF-E2 interacts with TAFII130 and mediates long-range activation of the alpha- and beta-globin gene loci in an erythroid cell line. Proc Natl Acad Sci U S A (1997) 1.12
Mapping of semantic, phonological, and orthographic verbal working memory in normal adults with functional magnetic resonance imaging. Neuropsychology (1999) 1.11
Sympathetic overactivity in tetanus: fatality associated with propranolol. Br Med J (1978) 1.11
Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet (2003) 1.10
Anemia and perinatal death result from loss of the murine ecotropic retrovirus receptor mCAT-1. Genes Dev (1997) 1.10
Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res (1998) 1.09
Familial segregation of venous thromboembolism. J Thromb Haemost (2004) 1.08
Alpha-synuclein, pesticides, and Parkinson disease: a case-control study. Neurology (2008) 1.07
Independent association of high blood pressure and aortic atherosclerosis: A population-based study. Circulation (2000) 1.05
Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J Biol Chem (1996) 1.05
The human cationic amino acid transporter (ATRC1): physical and genetic mapping to 13q12-q14. Genomics (1992) 1.04
Methylation-enhanced binding of Sp1 to the stage selector element of the human gamma-globin gene promoter may regulate development specificity of expression. Mol Cell Biol (1993) 1.04
Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol Cell Endocrinol (1996) 1.04
Distribution of ten laminin chains in dystrophic and regenerating muscles. Neuromuscul Disord (1999) 1.04
Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an 'adult' acetylcholine receptor subunit. Development (1997) 1.04
Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol (2001) 1.03
A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes. Biotechnol Prog (1992) 1.03
Functional MRI evidence for subcortical participation in conceptual reasoning skills. Neuroreport (1997) 1.01
A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology (2001) 1.00
Dimethyl sulphoxide induces a reduced growth rate, altered cell morphology and increased epidermal-growth-factor binding in Hep G2 cells. Biochem J (1991) 0.99
Autoimmune pathogenesis of paraneoplastic neurological syndromes. Crit Rev Neurobiol (1987) 0.99
Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation. Int J Oncol (1999) 0.98
To bedlam and back. J Psychosoc Nurs Ment Health Serv (1986) 0.98
Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors. J Biol Chem (2000) 0.96
Novel pattern of P53 mutation in breast cancers from Austrian women. J Clin Invest (1995) 0.95
Acetylcholine receptors in small cell carcinomas. J Neurochem (1985) 0.95
Left atrial appendage flow velocities in subjects with normal left ventricular function. Am J Cardiol (2000) 0.94
Effects of late gestational high-fat diet on body weight, metabolic regulation and adipokine expression in offspring. Int J Obes (Lond) (2013) 0.94
Retroviral infection and expression of cationic amino acid transporters in rodent hepatocytes. J Virol (1993) 0.94
Identification of two novel regulatory elements within the 5'-untranslated region of the human A gamma-globin gene. J Biol Chem (1995) 0.94
Men transmit MS more often to their children vs women: the Carter effect. Neurology (2006) 0.94
High frequency of p53 gene mutations in primary breast cancers in Japanese women, a low-incidence population. Br J Cancer (1996) 0.94
Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis. J Neurol Neurosurg Psychiatry (2006) 0.92
SPTLC1 and RAB7 mutation analysis in dominantly inherited and idiopathic sensory neuropathies. J Neurol Neurosurg Psychiatry (2005) 0.92
Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. Biol Blood Marrow Transplant (2003) 0.89